Article

Genetic Characterization of Antigenic Variant Infectious Bursal Disease Virus (IBDV) in Chickens in Korea

Jong-Yeol Park1https://orcid.org/0000-0002-5389-6387, Ki-Woong Kim1,2https://orcid.org/0000-0002-9204-6422, Ke Shang3https://orcid.org/0000-0001-5617-2168, Sang-Won Kim1https://orcid.org/0000-0002-4738-0341, Yu-Ri Choi1https://orcid.org/0000-0002-6913-087X, Cheng-Dong Yu1https://orcid.org/0009-0006-1206-5145, Ji-Eun Son1https://orcid.org/0009-0003-5414-0367, Gyeong-Jun Kim1https://orcid.org/0009-0003-0461-8967, Won-Bin Jeon1https://orcid.org/0009-0006-1337-963X, In-Hwan Kim1https://orcid.org/0009-0005-0567-5052, Bai Wei4https://orcid.org/0000-0003-1169-2500, Min Kang2,4https://orcid.org/0000-0001-5650-1144, Hyung-Kwan Jang4,https://orcid.org/0000-0003-3542-3620, Se-Yeoun Cha4,https://orcid.org/0000-0001-5745-4845
Author Information & Copyright
1Researcher, Department of Veterinary Infectious Diseases and Avian Diseases, College of Veterinary Medicine and Center for Avian Diseases, Jeonbuk National University, Iksan 54596, Republic of Korea
2Researcher, Bio Disease Control(BIOD) Co., Ltd., Iksan 54596, Republic of Korea
3Professor, The Key Lab of Animal Disease and Public Health/Luoyang Key Laboratory of Live Carrier Biomaterial and Animal Disease Prevention and Control, Henan University of Science and Technology, Luoyang 471000, Henan, China
4Professor, Department of Veterinary Infectious Diseases and Avian Diseases, College of Veterinary Medicine and Center for Avian Diseases, Jeonbuk National University,Iksan 54596, Republic of Korea
To whom co-correspondence should be addressed : seyeouncha@gmail.com, hkjang@jbnu.ac.kr

© Copyright 2023, Korean Society of Poultry Science. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Nov 25, 2023; Revised: Dec 01, 2023; Accepted: Dec 04, 2023

Published Online: Dec 31, 2023

ABSTRACT

Infectious bursal disease (IBD) is an acute, highly contagious, and immunosuppressive disease in young chickens, and causes considerable economic losses to the poultry industry. More than 30 years ago, an antigenic variant IBDV (avIBDV) was reported in chicken farms in the United States. Recently, a novel avIBDV exhibited clear differences in molecular characteristics compared with previous variant strains. This study investigated the molecular characteristics of recently isolated avIBDV strains in Korea. Strains of avIBDV were confirmed by reverse transcription PCR (RT-PCR) and were propagated in 10-day-old specific-pathogen-free (SPF) embryonated chicken eggs through chorioallantoic membrane (CAM) inoculation. Multiple sequence alignment and phylogenetic analyses of hypervariable regions VP2 gene revealed that the strains originated from two different avIBDV lineages (G2a and G2d). In our results, we confirmed the co-existence and prevalence of avIBDV genogroup G2a and G2d in chicken farms. It is necessary to study the protective efficacy of current vaccines against avIBDVs.

Keywords: antigenic variant; infectious bursal disease; phylogenetic tree; VP2 gene

INTRODUCTION

Infectious bursal disease (IBD), an acute, highly contagious, and immunosuppressive disease in young chickens, causes considerable economic losses to the poultry industry. Infectious bursal disease virus (IBDV) destroys B-lymphocytes in the bursa of Fabricius of young chickens, inducing immunosuppression (Jackwood, 2017; Saif, 1991). IBDVs are classified under the Avibirnavirus genus of the Birnaviridae family, have a non-enveloped icosahedral capsid with a double-stranded RNA (dsRNA) genome with two segments (segments A and B). Segment A is approximately 3.2 kb and contains two open reading frames (ORFs) that encode viral proteins including VP5, VP2, VP4 and VP3 (Fahey et al., 1989; Bayliss et al., 1990). VP2 is the major structural protein, which is involved in antigenicity, cell tropism, virulence and apoptosis (Coulibaly et al., 2005). The amino acid (aa) residues 206−350 of VP2 have been identified as the hypervariable region (HVR) which contains four hydrophilic regions, including aa 210−225 (peak A), 247−254 (minor peak 1), 281−292 (minor peak 2), and 312−324 (peak B) (Letzel et al., 2007). Segment B is approximately 2.8 kb and encodes VP1, an RNA-dependent RNA polymerase (RdRp), which plays an important role in viral replication and genetic evolution (Escaffre et al., 2013).

IBDVs are divided serotypes I and II. Serotype I IBDVs are pathogenic to chickens and are further classified into seven subtypes, classical / attenuated IBDV (cv/at IBDV, G1), antigenic variant IBDV (avIBDV, G2), very virulent IBDV (vvIBDV, G3), distinct (d) IBDV (dIBDV, G4), variant / classical recombinant (G5), dIBDV from Italy (G6) and Australia (G7) (Jackwood et al., 2018). Serotype II IBDVs have been isolated from turkeys and are nonpathogenic to chickens (Ismail et al., 1988).

IBDV was first isolated in 1957 in the United States (Cosgrove, 1962). Subsequently vvIBDV and avIBDV have emerged (Chettle et al., 1989; Jackwood and Saif, 1987). Over the past 30 years, vvIBDV with an extremely high mortality rate has caused considerable economic losses to the poultry industry (Jackwood, 2017). Intermediate or intermediate plus live attenuated vaccines and inactivated vaccines were widely used to control IBDV infection, and vvIBDV is well contained worldwide. However, in recent years, novel avIBDV that emerged in China rapidly spread to other countries (Fan et al., 2019; Thai et al., 2021; Xu et al., 2020). avIBDV has no mortality but causes severe atrophy of the bursa of Fabricius and induces severe immunosuppression in chickens (Fan et al., 2019; Xu et al., 2020). In South Korea, the first IBD outbreak was reported in 1980 and four genogroups of IBDV (G1-G4) have been isolated to date (Jeon et al., 2009; Kim et al., 2010; Kwon et al., 2000). In the present study, we focused on the genetic and pathogenic characterization of the avIBDV from chickens in Korea. This study provides information about genetic and pathogenic characterization of currently circulating avIBDV in Korea.

MATERIALS & METHODS

1. Sample Collection

Bursal samples were collected between 2019 and 2020 from suspected IBDV-infected chickens from chicken farms (Jeonbuk and Gyeongki provinces). Bursal samples were homogenized in 10% (w/v) phosphate buffered saline [PBS, pH 7.4; supplemented with 100× antibiotic−antimycotic (Gibco, New York, USA)]. The homogenates were centrifuged at 3,000×g for 10 min at 4°C, and the supernatant was collected for subsequent IBDV detection and analysis. The supernatant was then conserved in aliquots at −70°C for virus isolation and viral RNA extraction.

2. Reverse Transcription PCR (RT-PCR) and Sequencing

Viral RNA was extracted from the clarified bursal samples using the 5X MagMAX™ − Pathogen RNA/DNA kit (Thermo Fisher Scientific, Vilnius, Lithuania) with KingFisher Duo Prime Purification system (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer’s protocol. Viral cDNA was generated from RNA samples using GoScript™ reverse transcriptase (Promega, Madison, WI, USA) with random primers (9‐mers; TaKaRa Bio. Inc., Otsu, Shiga, Japan). In the reverse transcription (RT) reaction, 8 μL of extracted RNA and 2 μL of dimethyl sulfoxide (Tedia, Ohio, Fairfield, USA) were heated at 100°C for 5 min and then placed in an ice bath for 5 min. Then, the following materials were added to this reaction mixture: 8 μL of GoScript™ 5X RT reaction buffer (Promega, Madison, WI, USA), 10 μL of 2.0 mM of each dNTP (SolGent, Daejeon, Korea), 4 μL of MgCl2 (Promega, Charbonniere, France), 1 μL of 20 units Recombinant RNasin® Ribonuclease Inhibitor (Promega, Madison, WI, USA), 1 μL of GoScript™ reverse transcriptase, 1 μL of 50 pmol random primer, and 4 μL of diethylpyrocarbonate-treated water (DEPC water; Biosesang, Seoul, Korea); a final volume of 39 μL was obtained. The RT reaction mixture was incubated in this sequence: 25°C for 5 min, 42°C for 60 min, and 70°C for 15 min to inactivate the enzyme (Kim et al., 2022). The RT-PCR was performed using the forward primer IBDV-F1 (5′-GCCCAGAGTCTACACCAT-3′) and the reverse primer IBDV-R1 (5′-CCCGGATTATGTCTTTGA-3′), which amplified 743-bp fragment covering the hypervariable region (HVR) of the VP2 gene (Jackwood et al., 2006). The RT-PCR products were purified and the nucleotide sequences assembled using an ABI 3730XL DNA Analyzer (Applied Biosystems, Foster City, CA, USA) by SolGent (Daejeon, Korea).

3. Sequence Analysis

Based on the nucleotide and deduced amino acid sequences of the VP2 HVR, phylogenetic analysis was conducted. Sequence alignments were performed on the nucleotide sequences using GENETYX software (Ver 6.1; Genetyx Corp., Tokyo, Japan). A 360-bp fragment (661−1,021 nt) of VP2 HVR was aligned, and phylogenetic trees were constructed using the neighbor-joining method and 1,000 bootstrap replications with the MEGA X software. (MEGA, 2018). The GenBank accession numbers and the nation of the reference strains used in this study are provided in Table 1.

Table 1. IBDV reference strains used in this study
Strain Origin Genotype Accession no Strain Origin Genotype Accession no
Lukert USA Genotype 1 AY918948 SHG49 China Genotype 2
(G2d)
MH879104
F52-70 Germany Genotype 1 AY321953 SHG165 China Genotype 2
(G2d)
MH925084
STC Canada Genotype 1 D00499 SHG232 China Genotype 2
(G2d)
MH879119
Int/228E Taiwan Genotype 1 AF457104 SHG352 China Genotype 2
(G2d)
MH879130
D78 USA Genotype 1 AF499929 ZD-2018-1 China Genotype 2
(G2d)
MN485882
CU-1 China Genotype 1 X16107 JBN2011 Korea Genotype 3 MF188862
V1 USA Genotype 2
(G2a)
AF281235 Chinju Korea Genotype 3 AF508177
09D243 Korea Genotype 2
(G2a)
GU646410 OKYM Japan Genotype 3 D49706
variant E USA Genotype 2
(G2a)
AF133904 HuB-1 China Genotype 3 EU042145
AL-2 USA Genotype 2
(G2a)
JF736011 HK46 China Genotype 3 AF051838
T1 USA Genotype 2
(G2b)
AF281238 TY2 Japan Genotype 4 LC136880
9109 USA Genotype 2
(G2b)
AY462027 K310 Korea Genotype 4 AF165149
19D38 Korea Genotype 2
(G2b)
MT550875 SNU9414 Korea Genotype 4 EU863754
19D44 Korea Genotype 2
(G2b)
MT550876 NVRI80029 Korea Genotype 4 FJ000316
3-1 USA Genotype 2
(G2c)
JX096965 Mexico04M92 Mexico Genotype 5 DQ916213
OH20092N USA Genotype 2
(G2c)
JX096986 Mexico04M101 Mexico Genotype 5 DQ916210
3 Ohio USA Genotype 2
(G2c)
MF142529 ITA-02 Italy Genotype 6 JN852986
19D51 Korea Genotype 2
(G2d)
MT550877 IBDVRF-5/94 Russia Genotype 6 Z97002
19D69 Korea Genotype 2
(G2d)
MT550878 002/73 Australia Genotype 7 AF148073
19D75 Korea Genotype 2
(G2d)
MT550879 08/95 Australia Genotype 7 AF148081
SHG19 China Genotype 2
(G2d)
MH879092 V877-W Australia Genotype 7 HM071991
Download Excel Table
4. Virus Isolation

Bursal homogenates were inoculated into 10-day-old specific pathogen-free (SPF) embryonated chicken eggs via the chorioallantoic membrane (CAM) route. Embryonated eggs were observed daily for 5 days by candling. At 5 days post-inoculation (dpi), CAM of the infected embryos were harvested and homogenized by freezing and thawing three times; then, 1.5 mL PBS was added, followed by centrifugation at 3,000×g for 10 min. The 50% embryo infectious dose (EID50) was calculated by the method of Reed and Meunch (Reed & Muench, 1938).

RESULTS

1. Detection and Isolation of IBDV

Four avIBDV strains were isolated and confirmed by RT-PCR. Details of these strains isolated from chicken farms are summarized in Table 2. Chickens originated from three broiler farms and one Korean native chicken farm. Most farms were reported to show low mortality rate but were co-infected with viral diseases such as inclusion body hepatitis (IBH) and infectious bronchitis (IB) and bacterial diseases such as Colibacillosis and Clostridial disease. Among these strains, two strains were isolated from IBDV-vaccinated chicken farms.

Table 2. Summary of variant strains of the infectious bursal disease virus (IBDV)
Isolates Species Province Population Age
(days)
Mortality
(%)
Vaccination Complicated disease Gross lesion Accession no.
A19-MRA-016 Broiler
(Ross)
Jeonbuk 40,000 18 0.3−0.8 nd1 Inclusion body hepatitis Erosion and inflammation OM310972
A20-ETC-014 Broiler
(Cobb)
Gyeongki 45,000 26 1.8 Yes
(13d)
Infectious bronchitis
Colibacillosis
Atrophy OM310973
A20-CFR-001 KNC2 Jeonbuk 39,000 43 0.4 Yes
(23d)
Inclusion body hepatitis
Chicken infectious anemia
Colibacillosis
Clostridium perfringens
Hemorrhagic and inflammation OM310974
A20-MRA-149 Broiler Jeonbuk 95,500 34 nd No No No lesion OM310975

1 No data.

2 Korean native chicken.

Download Excel Table
2. Molecular Characterization of avIBDV Strains

Phylogenetic analysis of VP2 HVR nucleotide sequences of reference strains showed that these strains were divided into seven major branches. The antigenic variant group (G2) was divided into four-sublineages (G2a, G2b, G2c and G2d). According to the phylogenetic analysis, all four strains in the present study were classified into one branch with the reference strains of the antigenic variant group (G2). A19-MRA-016 was clustered with the representative avIBDV strains from G2a lineage which were demonstrated in America and Korea (V1, and 09D243 strains, respectively). A20-ETC-014, A20-CFR-001 and A20-MRA-149 were clustered G2d lineage together with SHG19 and ZD-2018-1 which recently emerged in China. A05-HL-144, which was used in pathogenicity experiment was clustered in the dIBDV group (G4) (Fig. 1).

kjps-50-4-231-g1
Fig. 1. Phylogenetic analysis of the nucleotide sequences of VP2 HVR (360 bp). Phylogenetic tree of hypervariable region of VP2 generated by the neighbor-joining method using MEGA X with 1,000 bootstrap replications. IBDV strains in present study identified in this study are indicated in bold.
Download Original Figure

The variant strains in the present study were classified into two lineages: G2a and G2d; and these strains showed obvious differences in VP2 gene sequence. A19-MRA-016 was more closely related to variant strains from G2a and G2b lineages (93.6−98.3% nucleotide sequence identity) than the G2d lineage (91.9−92.5% nucleotide sequence identity). Additionally, A20-ETC-014, A20-CFR-001, and A20-MRA-149 showed 96.1−100% nucleotide sequence identity within the G2d, which was higher than the identity to the previous lineages in G2a (91.9−93.6%, nucleotide sequence identity) (Table 3).

Table 3. The key amino acid substitutions in VP2 HVR
A20-MRA-149
A20-CFR-001 100
SHG49 97.78 97.78
SHG352 97.22 97.22 96.94
SHG232 98.33 98.33 97.78 98.33
A20-ETC-014 96.11 96.11 96.11 96.67 97.22
SHG165 96.39 96.39 96.39 96.39 97.50 98.61
SHG19 96.39 96.39 96.11 96.11 97.22 98.33 98.61
A19-MRA-016 91.94 91.94 91.94 92.22 91.94 92.50 92.22 92.50
V1 93.04 93.04 93.04 93.04 93.04 93.59 93.32 93.59 96.10
09D243 92.22 92.22 91.94 91.94 92.22 91.94 92.22 92.50 98.33 96.66
A05-HL-144 87.92 87.92 88.20 88.76 88.76 88.48 88.48 88.76 90.81 90.83 90.81
% A20-MRA-149 A20-CFR-001 SHG49 SHG352 SHG232 A20-ETC-014 SHG165 SHG19 A19-MRA-016 V1 09D243 A05-HL-144
Download Excel Table

Further molecular characterization of avIBDVs was conducted by multiple alignments of the deduced amino acid sequences of HVRs of the VP2 gene (221 to 340 aa). All the variant IBDV strains possessed similar typical amino acid residues 222T, 249K, and 286I. Notably, two conserved amino acid residues including 252I, and 299S were only existed in the Chinese variant IBDVs (G2d), which are distinctly different from the American variants (G2a) (Table 4).

Table 4. The key amino acid substitutions in VP2 HVR
Strain Genogroup Amino acid positions (VP2)
221 222 242 249 252 253 256 279 284 286 294 299 318 330
A20-CFR-001 G2d (avIBDV) K T V K I Q V N A I L S D S
A20-ETC-014 G2d (avIBDV) K T V K I Q V N A I L S D S
A20-MRA-149 G2d (avIBDV) K T V K I Q V N A I L S D S
19D51 G2d (avIBDV) K T V K I Q V N A I L S D S
SHG19 G2d (avIBDV) K T V K I Q V N A I L S D S
SHG49 G2d (avIBDV) K T V K I Q V N A I L S D S
ZD-2018-1 G2d (avIBDV) K T V K I Q V N A I L S D S
Variant E G2a (avIBDV) Q T V K V Q V N A I L N D S
A19-MRA-016 G2a (avIBDV) K T V K V Q V N A I L N D S
09D243 G2a (avIBDV) K T V K V Q V N A I L N D S
9109 G2b (avIBDV) Q T V K V Q V N A I L N N S
19D38 G2b (avIBDV) Q T V K V Q V N A I L N N S
F52/70 G1 (cv/at) Q P I Q V Q V D A T L N G S
D78 G1 (cv/at) Q P V Q V H V N T T L N G R
HK46 G3 (vvIBDV) Q A I Q V Q I D A T I S G S
OKYM G3 (vvIBDV) Q A I Q V Q I D A T I S G S
TY-2 G4 (dIBDV) Q S V Q V Q V N A T L H G S
A05-HL-144 G4 (dIBDV) Q S V Q V Q T N A T L N D S
Mexico04M101 G5 Q T V Q V Q V N A T L N D S
IBDV/Italy/1829/2011 G6 Q Q V Q V E K D A T L S G S
V877 G7 Q P V Q V Q V G A T L S G S
Download Excel Table

DISCUSSION

Infectious bursal disease (IBD) is an acute, highly contagious and immunosuppressive disease in young chickens, causes considerable economic losses to the poultry industry (Van den Berg et al., 2000). Since the first emergence of classic IBDV in the USA was documented in 1957, and avIBDV was reported in the USA in 1987, which evaded the immune protection of classic IBDV (Cosgrove, 1962; Jackwood & Saif, 1987). However, over the past 30 years, avIBDV was neglected because of the subsequent cases of vvIBDV, which has high mortality and morbidity with economic losses (Jackwood et al., 2006). However, the novel avIBDV emerged in 2019 in China (Fan et al., 2019). This avIBDV has a low mortality, but it causes severe atrophy of bursa, which induces immunosuppression and avIBDV-infected birds are susceptible to secondary infection of bacterial and viral diseases such as IB, IBH, colibacillosis (Berg, 2000; Jackwood, 2017; Xu et al., 2020).

In our study, four avIBDVs were detected in Korean broilers and native chickens. Among the four avIBDVs, two were isolated from chicken farms immunized with the intermediate-plus IBDV vaccine. However, gross lesions such as atrophy and inflammation in these birds showed no differences as compared to non-vaccinated chickens. Also, three isolates were co-infected with other viral and bacterial diseases. In previous studies, the commercial vaccines against avIBDV may not have provided complete protection to chickens (Fan et al., 2019). Therefore, it is necessary to evaluate the efficacy evaluation of the avIBDV of the current commercial vaccine, and continuous surveillance of the avIBDV is also needed. In addition, it is imperative to study the immunosuppressive properties of the avIBDV and the risk of co-infection with other viral and bacterial diseases.

VP2 gene is a capsid protein of IBDV and includes a P domain. The P domain is involved in antigenicity and host cell adhesion. The HVR of the VP2 gene is frequently used for genetic analysis of IBDV (Coulibaly et al., 2010; Jackwood et al., 2018). All four isolates in this study belonged to the antigenic variant group (G2). Three of the isolates belonged to the G2d group, which is a novel avIBDV that recently occurred in China, and one of isolates belonged to the G2a group, similar to the American variant strain. A novel antigenic variant IBDV was first reported in China in 2019, and is also being detected in Korea, Japan, and Malaysia (Aliyu et al., 2021; Fan et al., 2019; Myint et al., 2021; Thai et al., 2021). In Korea, the avIBDV 09D243 similar to the Variant E was first reported in 2010 (Kim et al., 2010). A total of 5 isolates were reported in 2021, including two isolates were in the G2b group and three were in the G2d group (Thai et al., 2021). In addition, although viruses such as K310, NVRI80029, and SNU 9414, similar to A05-HL-144 used in this study, were reported as Korean antigenic variants, these strains were regarded as dIBDV and classified as genotype 4 (Jeon et al., 2009; Kwon et al., 2000; Tomás et al., 2019). Furthermore, the Chinese variant IBDVs (G2d) were obviously different from the American variant IBDVs (G2a, G2b). A20-ETC-014, A20-CFR-001, and A20-MRA-149 showed 96.1−100% sequence identity with the G2d, which was higher than the identity to the previous other lineages (91.9−93.6%). Therefore, it is important to study the transmission of avIBDV, and to study the effect of the genome mutations in antigenic variant strains on the pathogenicity in the chicken.

As a result of amino acid (aa) analysis of VP2 gene HVR, characteristic amino acids, including 222T, 249K, and 286I mutations were identified. In the case of 222 (aa), it changes the reactivity of monoclonal antibodies and induces immune evasion (Jackwood & Sommer-Wagner, 2011; Michel & Jackwood, 2017). In the case of 249 (aa), it was confirmed that the virulence was weakened when the Q249R mutation occurred, providing evidence related to virulence (Qi et al., 2013).

Compared with the American antigenic variant IBDV, distinct amino acid residues in VP2 (252I and 299S) were observed in the Chinese variant IBDVs (Fan et al., 2019). In the case of 299S, it is both a characteristic amino acid appearing in antigenic variants and one of the characteristic amino acids of very virulent IBDV. The biological role of these amino acids is unknown. Therefore, it is necessary to study the effect of amino acid mutations on pathogenicity (Jackwood et al., 2018).

In conclusion, we reported the co-occurrence of different sub-lineages of avIBDVs in South Korea. In addition, we show the possibility that avIBDVs cannot be controlled using the current anti-IBDV vaccine, considering their continuous occurrence in vaccinated flocks. Therefore, it is necessary to evaluate the efficacy of current commercial vaccines and pathogenicity tests.

SUMMARY

전염성 F낭병은 닭에서 F낭의 위축 및 염증이 나타나고, 이로 인해 면역억제를 특징으로 하며, 급성, 높은 점염성을 가지는 질병이다. VP2 유전자의 염기서열 분석을 통해 유전형이 분류되고, 유전형에 따라 항원성 및 병원성에 큰 차이를 나타내고 있다. 최근 중국에서 발생한 항원 변이주의 경우, 기존의 미국형 항원 변이주와는 다른 분자 특성을 보이는 것으로 나타났다. 최근 국내에서도 이러한 중국형 항원 변이주가 발생하고 있고, 따라서 본 연구에서는 국내 양계농장에서 분리된 항원 변이주의 유전체 분석을 통한 분자적 특성을 확인하였다. 국내 육계 및 토종닭으로부터 4개의 항원 변이주를 RT-PCR을 통해 확인하였고, chorioallantoic membrane 접종을 통해 분리하였다. VP2 유전자의 hypervariable region의 분석 결과, 4개의 항원 변이주 중 1개는 미국형 항원 변이주로 확인되었고, 이는 2009년 국내에서 보고된 09D243 균주와 유사한 것으로 나타났으며, 3개의 중국형 항원 변이주는 최근 국내 및 중국의 유행주와 유사한 것으로 확인되었다. 우리의 결과에서 국내 양계농장에서 중국형 및 미국형 항원 변이주가 퍼져 있음을 확인하였고, 또한 백신을 접종한 농장에서의 발생도 이뤄지고 있어 항원 변이주에 대한 상용화 백신의 보호 효능에 대한 연구도 필요합니다.

ACKNOWLEDGMENTS

This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry(IPET) through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (320005-4, 122014-2, 122059-2).

REFERENCES

1.

Aliyu HB, Hair-Bejo M, Omar AR, Ideris A 2021 Genetic diversity of recent infectious bursal disease viruses isolated from vaccinated poultry flocks in Malaysia. Front Vet Sci 8:643976.
, ,

2.

Bayliss C, Spies U, Shaw K, Peters R, Papageorgiou A, Müller H, Boursnell M 1990 A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. J Gen Virol 71(6):1303-1312.
,

3.

Berg TP 2000 Acute infectious bursal disease in poultry: a review. Avian Pathol 29(3):175-194.
,

4.

Chettle N, Stuart J, Wyeth P 1989 Outbreak of virulent infectious bursal disease in East Anglia. Vet Rec 125(10): 271-272.
,

5.

Cosgrove A 1962 An apparently new disease of chickens: avian nephrosis. Avian Dis 6(3):385-389.

6.

Coulibaly F, Chevalier C, Delmas B, Rey FA 2010 Crystal structure of an Aquabirnavirus particle: insights into antigenic diversity and virulence determinism. J Virol 84(4): 1792-1799.
, ,

7.

Coulibaly F, Chevalier C, Gutsche I, Pous J, Navaza J, Bressanelli S, Delmas B, Rey FA 2005 The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120(6):761-772.
,

8.

Escaffre O, Le Nouën C, Amelot M, Ambroggio X, Ogden KM, Guionie O, Toquin D, Müller H, Islam MR, Eterradossi N 2013 Both genome segments contribute to the pathogenicity of very virulent infectious bursal disease virus. J Virol 87(5):2767-2780.
, ,

9.

Fahey KJ, Erny K, Crooks J 1989 A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70(6):1473-1481.
,

10.

Fan L, Wu T, Hussain A, Gao Y, Zeng X, Wang Y, Gao L, Li K, Wang Y, Liu C 2019 Novel variant strains of infectious bursal disease virus isolated in China. Vet Micro 230:212-220.
,

11.

Ismail NM, Saif YM, Moorhead PD 1988. Lack of pathogenicity of five serotype 2 infectious bursal disease viruses in chickens. Avian Dis 32(4):757-759.
,

12.

Jackwood D, Cookson K, Sommer-Wagner S, Galludec HL, De Wit J 2006 Molecular characteristics of infectious bursal disease viruses from asymptomatic broiler flocks in Europe. Avian Dis 50(4):532-536.
,

13.

Jackwood DH, Saif YM 1987 Antigenic diversity of infectious bursal disease viruses. Avian Dis 31(4):766-770.
,

14.

Jackwood DJ 2017 Advances in vaccine research against economically important viral diseases of food animals: infectious bursal disease virus.Vet Micro 206:121-125.
,

15.

Jackwood DJ, Schat KA, Michel LO, de Wit S 2018) A proposed nomenclature for infectious bursal disease virus isolates. Avian Pathol 47(6):576-584.
,

16.

Jackwood DJ, Sommer-Wagner SE 2011 Amino acids contributing to antigenic drift in the infectious bursal disease Birnavirus (IBDV). Virol 409(1):33-37.
,

17.

Jeon WJ, Choi KS, Lee DW, Lee EK, Cha SH, Cho SH, Kwon JH, YoonYS, Kim SJ, Kim JH 2009 Molecular epizootiology of infectious bursal disease (IBD) in Korea. Virus Genes 39(3):342-351.
,

18.

Kim HR, KwonYK, Bae YC, Oem JK, Lee OS 2010 Genetic characteristics of virion protein 2 genes of infectious bursal disease viruses isolated from commercial chickens with clinical disease in South Korea. Poul Sci 89(8):1642-1646.
,

19.

Kim SW, Choi YR, Park JY, Wei B, Shang K, Zhang JF, Jang HK, Cha SY, Kang M 2022 Isolation and genomic characterization of avian reovirus from wild birds in South Korea. Front Vet Sci 9:794934.
, ,

20.

Kwon HM, Kim DK, Hahn TW, Han JH, Jackwood DJ 2000 Sequence of precursor polyprotein gene (segment A) of infectious bursal disease viruses isolated in Korea. Avian Dis 44(3):691-696.
,

21.

Letzel T, Coulibaly F, Rey FA, Delmas B, Jagt E, Van Loon AA, Mundt E 2007 Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. J Virol 81(23):12827-12835.
, ,

22.

Lucio B, Hitchner SB 1979 Response of susceptible versus immune chicks to killed, live-modified, and wild infectious bursal disease virus vaccines. Avian Dis 23(4): 1037-1050.
,

23.

Kumar S, Stecher G, Li M, Knyaz C, Tamura K 2018 MEGA X: Molecular evolutionary genetics analysis across computing platforms Mol Biol Evol 35(6):1547-1549.
, ,

24.

Michel LO, Jackwood DJ 2017 Classification of infectious bursal disease virus into genogroups. Arch Virol 162(12): 3661-3670.
, ,

25.

Myint O, Suwanruengsri M, Araki K, Izzati UZ, Pornthummawat A, Nueangphuet P, Fuke N, Hirai T, Jackwood DJ, Yamaguchi R 2021 Bursa atrophy at 28 days old caused by variant infectious bursal disease virus has a negative economic impact on broiler farms in Japan. Avian Pathol 50(1):6-17.
,

26.

Qi X, Zhang L, Chen Y, Gao L, Wu G, Qin L, Wang Y, Ren X, Gao Y, Gao H 2013 Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious bursal disease virus. Plos one 8(7):e70982.
, ,

27.

Reed LJ, Muench H 1938 A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27(3):493-497.

28.

Saif Y 1991 Immunosuppression induced by infectious bursal disease virus. Vet Immunol Immunopathol 30(1):45-50.
,

29.

Sharma JM, Dohms JE, Metz AL 1989 Comparative pathogenesis of serotype 1 and variant serotype 1 isolates of infectious bursal disease virus and their effect on humoral and cellular immune competence of specific-pathogen-free chickens. Avian Dis 33(1):112-124.
,

30.

Thai TN, Jang I, Kim HA, Kim HS, Kwon YK, Kim HR 2021 Characterization of antigenic variant infectious bursal disease virus strains identified in South Korea. Avian Pahol 50(2):174-181.
,

31.

Tomás G, Marandino A, Courtillon C, Amelot M, Keita A, Pikula A, Hernández M, Hernández D, Vagnozzi A, Panzera Y 2019 Antigenicity, pathogenicity and immunosuppressive effect caused by a South American isolate of infectious bursal disease virus belonging to the “distinct” genetic lineage. Avian Pathol 48(3):245-254.
,

32.

Van den Berg T, Eterradossi N, Toquin D, Meulemans G 2000 Infectious bursal disease (Gumboro disease). OIE 19 (2):509-543.

33.

Xu A, Pei Y, Zhang K, Xue J, Ruan S, Zhang G 2020 Phylogenetic analyses and pathogenicity of a variant infectious bursal disease virus strain isolated in China. Virus Res 276:197833.
,